CRS3123, identified by its CAS number 1013915-71-3, is a chemical compound that has garnered attention in various research contexts, particularly in the field of medicinal chemistry. While specific details about its physical and chemical properties may vary, compounds of this nature typically exhibit characteristics such as a defined molecular structure, which influences their reactivity and interaction with biological systems. CRS3123 is often studied for its potential therapeutic applications, particularly in relation to its mechanism of action and efficacy in targeting specific biological pathways. The compound may also possess unique solubility and stability profiles, which are critical for its formulation and delivery in pharmaceutical contexts. Additionally, safety and toxicity assessments are essential for understanding its suitability for use in clinical settings. As research continues, further insights into its characteristics and applications are likely to emerge, contributing to the broader understanding of its role in drug development and therapeutic interventions.

CRS3123

1013915-71-3: CRS3123, identified by its CAS number 1013915-71-3, is a chemical compound that has garnered attention in various research contexts, particularly in the field of medicinal chemistry. While specific details about its physical and chemical properties may vary, compounds of this nature typically exhibit characteristics such as a defined molecular structure, which influences their reactivity and interaction with biological systems. CRS3123 is often studied for its potential therapeutic applications, particularly in relation to its mechanism of action and efficacy in targeting specific biological pathways. The compound may also possess unique solubility and stability profiles, which are critical for its formulation and delivery in pharmaceutical contexts. Additionally, safety and toxicity assessments are essential for understanding its suitability for use in clinical settings. As research continues, further insights into its characteristics and applications are likely to emerge, contributing to the broader understanding of its role in drug development and therapeutic interventions.

<p>CRS-3123, a methionyl-tRNA synthetase inhibitor, is used potentially for the treatment of enteric infections.</p>

CAS 1013915-71-3

CRS3123

CRS-3123

Ref: TM-T27088